Home

Intelligence

Services

Subscriptions

News

About Us

Sign In

 

Document Preview

Convertible Debenture

 

Click "Add to Cart" button to purchase document. 
Documents are emailed immediately after purchase. 
You can also browse documents by
title, category, or company... or click here for help finding documents.

 

Title:

Convertible Debenture

Entities:

Hemispherx BioPharma, Inc.; Interferon Sciences, Inc.; Schulte Roth & Zabel LLP

Date:

2003

Size:

Preview shows 8KB of 177KB total

Price:

$58

ID:

#160776

 

 

► Financing ► Debentures ► Convertible Debentures
► Services ► Legal
► Miscellany ► Watch List
► Biotech & Drugs ► Biological Products

 

 

Start of Preview




THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY
NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN
EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF
1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS OR (B) AN OPINION OF
COUNSEL, REASONABLY SATISFACTORY TO THE COMPANY, THAT REGISTRATION IS NOT
REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY
BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED
BY THE SECURITIES.

THE FOLLOWING INFORMATION IS PROVIDED SOLELY FOR PURPOSES OF APPLYING THE U.S.
FEDERAL INCOME TAX ORIGINAL ISSUE DISCOUNT ("OID") RULES TO THIS DEBENTURE. THIS
DEBENTURE HAS AN ISSUE PRICE OF $3,550,000, AN AGGREGATE AMOUNT OF OID OF
$592,357, AN ISSUE DATE OF OCTOBER 29, 2003 AND A YIELD TO MATURITY OF 14.33 %.

No. __ $________

HEMISPHERX BIOPHARMA, INC.

6% SENIOR SECURED CONVERTIBLE DEBENTURE DUE OCTOBER 31, 2005

THIS DEBENTURE (this "Debenture") is one of a duly authorized issue
of Debentures of HEMISPHERX BIOPHARMA, INC., a corporation duly organized and
existing under the laws of the State of Delaware (the "Company"), designated as
its 6% Senior Secured Convertible Debentures Due October 31, 2005, in an
aggregate principal amount of up to Four Million, One Hundred Forty-Two Thousand
Three Hundred Fifty-Seven U.S. Dollars (U.S. $4,142,357) (the "Debentures").

FOR VALUE RECEIVED, the Company promises to pay to ________________,
the holder hereof, or its registered assigns (the "Holder"), the principal sum
of _____ Million Dollars ($_________) on October 31, 2005 (subject to extension
as provided herein, the "Maturity Date") and to pay interest ("Interest
Payments") on the Outstanding Principal Amount at the rate of 6% per annum which
shall be cumulative, accrue, but not compound, daily from the date of issuance
of this Debenture and be due and payable in arrears on the first day of each
Quarterly Period commencing with the Quarterly Period immediately following the
date of issuance of this Debenture (each, an "Interest Payment Date"). If the
Maturity Date is not a Business Day, then the Maturity Date shall be deemed to
be the Business Day immediately following such date. If an Interest Payment Date
is not a Business Day, then the Interest Payment shall be due and payable on the
Business Day immediately following such Interest Payment Date. Subject to the
limitations in Sections 11 and 26, interest shall be payable by the issuance of
shares of Common Stock ("Interest Shares") to the Holder or, at the option of
the Company, in cash (the "Cash Interest Payment"); provided, however, that the
Company may not make Cash Interest Payments and interest payments shall be
payable in Interest Shares unless the Company provides written notice to each
holder of Debentures at least five Business Days prior to the applicable
Interest Payment Date that such Interest Payments shall be made in cash.


1
{PAGE}

Interest Shares shall be paid in a number of fully paid and nonassessable shares
(rounded up or down to the nearest whole share) of Common Stock equal to the
quotient of (1) the amount of the Interest Payment due on the applicable
Interest Payment Date divided by (2) ninety-five percent (95%) of the arithmetic
average of the Closing Sale Price of the Common Stock on the five consecutive
Business Days ending on and including the third Business Day immediately
preceding the applicable Interest Payment Date (the "Interest Share Conversion
Rate"); provided, further; that in no event may the Company issue more than an
aggregate of 40,000 shares of Common Stock (as equitably adjusted for any stock
dividend, stock split or other similar transaction), pro rata among all holders
of Debentures, in respect of any single Interest Payment (it being understood
that the balance of each such Interest Payment shall be paid in the form of a
Cash Interest Payment). Notwithstanding the foregoing, the Company shall be
required to make a Cash Interest Payment on any Interest Payment Date if (a) any
event constituting an Event of Default or an event that with the passage of time
and without being cured would constitute an Event of Default, has occurred and
is continuing on the Interest Payment Date or any date which is within 10
Business Days prior to the Interest Payment Date, unless otherwise consented to
in writing by the holder of the Debenture entitled to receive such Interest
Payment or (b) from and after the time that any Registration Statement (as
defined in the Registration Rights Agreement, the "Registration Statement") is
required to be effective, such Registration Statement is not then effective and
available for the resale of all of the Registrable Securities (as defined in the
Registration Rights Agreement) on the Interest Payment Date or each date which
is within 10 Business Days prior to the Interest Payment Date. Any accrued and
unpaid interest which is not paid within five (5) Business Days of the Interest
Payment Date on which such payment of interest was due shall bear interest at
the rate of 14.0% per annum from such Interest Payment Date until the same is
paid in full (or, if less, the maximum interest rate then permitted by
applicable law) (the "Default Interest").

Interest Payments and payments of principal will be paid only to the
person in whose name this Debenture (or one or more predecessor Debentures) is
registered on the records of the Company regarding registration and transfers of
the Debentures (the "Debenture Register").

This Debenture is subject to the following additional provisions:

1. Exchange. The Debentures are exchangeable for an equal aggregate
principal amount of Debentures of different denominations, as requested by the
Holder surrendering the same. No service charge will be charged to the Holder
for such registration transfer or exchange.

2. Transfers. This Debenture has been issued subject to investment
representations of the original purchaser hereof and may be transferred or
exchanged in the United States only in compliance with the Securities Act of
1933, as amended (the "Act"), and applicable state securities laws. Prior to due
presentment for transfer of this Debenture, the Company may treat the person in
whose name this Debenture is duly registered on the Company's Debenture Register
as the owner hereof for the purpose of receiving payment as herein provided and
all other purposes, whether or not this Debenture is overdue, and the Company

 

End of Preview

 

Home        Intelligence        Services        Subscriptions        News        About Us

Contact Us       Terms of Use       Resend Documents       Shopping Cart

Copyright © 2008 The Consus Group LLC